The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
about
Antifactor Xa levels versus activated partial thromboplastin time for monitoring unfractionated heparin.Anticoagulant use in real time.A century of heparin: past, present and future.Effectiveness of Unfractionated Heparin in Normal Saline versus Dextrose for Achieving and Maintaining Therapeutic Anti-Factor Xa Levels in Patients with Non-ST-Elevation Acute Coronary Syndrome.A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
P2860
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@en
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@nl
type
label
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@en
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@nl
prefLabel
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@en
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@nl
P2093
P2860
P356
P1476
The use of anti-Xa assay to monitor intravenous unfractionated heparin therapy.
@en
P2093
Aimée LeClaire
Amy Fann Rosenberg
Lisa Taylor
Marc Zumberg
Neil Harris
P2860
P304
P356
10.1177/0897190010362172
P577
2010-05-06T00:00:00Z